Description
Hormonal oral contraceptives are the most effective contraceptive method used by women. In addition, in some cases, doctors prescribe such drugs to improve a woman's hormonal background when planning pregnancy. However, taking hormonal contraceptives is associated with an increased risk of increased blood clotting and the development of thrombosis. Risk factors include being overweight, smoking, and genetic predisposition to increased blood clotting. If a patient has a history of these factors, the decision to prescribe hormonal contraceptives should be made with caution and under the supervision of a doctor. The analysis includes a molecular genetic study of blood coagulation factor II and V genes to identify the risk of taking oral hormonal contraceptives and make the right decision about the safest family planning method for health.
Investigated genetic markers: F2 (G20210A), F5 (G1691A).
The examination results are provided with an interpretation by a geneticist.
Period of execution
Within 6 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Buccal (cheek) epithelium
- Venous blood